Skip to search formSkip to main contentSkip to account menu

oral anticoagulants

Known as: anticoagulant oral, anticoagulants oral, oral anticoagulant 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Thrombotic events are a major complication of cardiovascular disease. Despite the availability of a large range of antithrombotic… 
Review
2013
Review
2013
BACKGROUND The new oral anticoagulants (NOAs) dabigatran, rivaroxaban, and apixaban have proved effective and safe when used in… 
Highly Cited
2013
Highly Cited
2013
AIMS Experiences with novel oral anticoagulants (NOACs) early after atrial fibrillation (AF) catheter ablation are limited and… 
2009
2009
Summary Subtherapeutic anticoagulation levels increase both the risk and severity of thromboembolism. The aim of this study was… 
2009
2009
BACKGROUND Inappropriate and subtherapeutic anticoagulants dosages may result in severe thromboembolic and bleeding complications… 
Highly Cited
1997
Highly Cited
1997
Summary Background. The long-term administration of oral anticoagulants to patients with mechanical heart valve prostheses is… 
Review
1995
Review
1995
Long-term antithrombotic therapy with oral anticoagulants or antiplatelet agents for survivors of acute myocardial infarction… 
Highly Cited
1988
Highly Cited
1988
Therapeutic control achieved by an anticoagulant clinic may be assessed by calculation of the proportion of time spent by the…